109 related articles for article (PubMed ID: 27830685)
1. [Immunoreactivity of chimeric proteins carrying poliovirus epitopes on the VP6 of rotavirus as a vector].
Pan XX; Zhao BX; Teng YM; Xia WY; Wang J; Li XF; Liao GY; Yang С; Chen YD
Mol Biol (Mosk); 2016; 50(5):828-837. PubMed ID: 27830685
[TBL] [Abstract][Full Text] [Related]
2. A new rotavirus VP6-based foreign epitope presenting vector and immunoreactivity of VP4 epitope chimeric proteins.
Teng Y; Zhao B; Pan X; Wen Y; Chen Y
Viral Immunol; 2014 Apr; 27(3):96-104. PubMed ID: 24702286
[TBL] [Abstract][Full Text] [Related]
3. Rotavirus VP7 epitope chimeric proteins elicit cross-immunoreactivity in guinea pigs.
Zhao B; Pan X; Teng Y; Xia W; Wang J; Wen Y; Chen Y
Virol Sin; 2015 Oct; 30(5):363-70. PubMed ID: 26459269
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and antigenicity of a recombinant chimeric protein containing epitopes of poliovirus type 1.
Pan XX; Wang J; Xia WY; Li XF; Yang LJ; Huang C; Chen YD
Acta Virol; 2016; 60(3):234-41. PubMed ID: 27640433
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the immunogenicity of a recombinant HSV-1 vector expressing human group C rotavirus VP6 protein.
Rota RP; Palacios CA; Temprana CF; Argüelles MH; Mandile MG; Mattion N; Laimbacher AS; Fraefel C; Castello AA; Glikmann G
J Virol Methods; 2018 Jun; 256():24-31. PubMed ID: 29496429
[TBL] [Abstract][Full Text] [Related]
6. Construction and characterization of a recombinant human adenovirus type 3 vector containing two foreign neutralizing epitopes in hexon.
Xue C; Tian X; Li X; Zhou Z; Su X; Zhou R
Virus Res; 2014 Apr; 183():67-74. PubMed ID: 24518297
[TBL] [Abstract][Full Text] [Related]
7. Mapping the subgroup epitopes of rotavirus protein VP6.
López S; Espinosa R; Greenberg HB; Arias CF
Virology; 1994 Oct; 204(1):153-62. PubMed ID: 7522369
[TBL] [Abstract][Full Text] [Related]
8. Molecular cloning and immunogenicity evaluation of rotavirus structural proteins as candidate vaccine.
El-Senousy WM; Shahein YE; Barakat AB; Ghanem HE; El-Hakim AE; Ameen SM
Int J Biol Macromol; 2013 Aug; 59():67-71. PubMed ID: 23588003
[TBL] [Abstract][Full Text] [Related]
9. [Antigen differences of genetic variants Abent+ and Abent- poliovirus vaccine strain of III type].
Shyrobokov VP; Kostenko IH; Nikolaienko IV
Mikrobiol Z; 2003; 65(4):29-36. PubMed ID: 14618784
[TBL] [Abstract][Full Text] [Related]
10. Negative selection on neutralization epitopes of poliovirus surface proteins: implications for prediction of candidate epitopes for immunization.
Suzuki Y
Gene; 2004 Mar; 328():127-33. PubMed ID: 15019992
[TBL] [Abstract][Full Text] [Related]
11. Self-assembling Rotavirus VP6 Nanoparticle Vaccines Expressed in Escherichia coli Elicit Systemic and Mucosal Responses in Mice.
Li Z; Cui K; Huang K; Liu F; Shi D; Liu Q
Protein Pept Lett; 2019; 26(12):904-909. PubMed ID: 31429685
[TBL] [Abstract][Full Text] [Related]
12. Homogeneous processing and presentation of a recombined T cell epitope in inbred mice of different non-MHC genetic background.
Lo-Man R; Martineau P; Hofnung M; Leclerc C
Cell Immunol; 1996 Sep; 172(2):180-91. PubMed ID: 8964079
[TBL] [Abstract][Full Text] [Related]
13. Immune responses elicited against rotavirus middle layer protein VP6 inhibit viral replication in vitro and in vivo.
Lappalainen S; Pastor AR; Tamminen K; López-Guerrero V; Esquivel-Guadarrama F; Palomares LA; Vesikari T; Blazevic V
Hum Vaccin Immunother; 2014; 10(7):2039-47. PubMed ID: 25424814
[TBL] [Abstract][Full Text] [Related]
14. [Protective efficacy of recombinant rotavirus epitope-based vaccine in mice].
Liu X; Li JQ; Xiong XY; Chen YN; Peng M; Dai Q; Wen YL; Chen YD
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Apr; 27(2):216-22. PubMed ID: 15960269
[TBL] [Abstract][Full Text] [Related]
15. Chimeric recombinant rotavirus-like particles as a vehicle for the display of heterologous epitopes.
Peralta A; Molinari P; Taboga O
Virol J; 2009 Nov; 6():192. PubMed ID: 19891790
[TBL] [Abstract][Full Text] [Related]
16. Peptide-Recombinant VP6 Protein Based Enzyme Immunoassay for the Detection of Group A Rotaviruses in Multiple Host Species.
Kumar N; Malik YS; Kumar S; Sharma K; Sircar S; Saurabh S; Gulati BR; Singh N; Singh AK; Joshi VG; Banyai K; Dhama K
PLoS One; 2016; 11(7):e0159027. PubMed ID: 27391106
[TBL] [Abstract][Full Text] [Related]
17. Identification of an immunodominant CD4+ T cell epitope in the VP6 protein of rotavirus following intranasal immunization of BALB/c mice.
McNeal MM; Basu M; Bean JA; Clements JD; Choi AH; Ward RL
Virology; 2007 Jul; 363(2):410-8. PubMed ID: 17337285
[TBL] [Abstract][Full Text] [Related]
18. Targeting of rotavirus VP6 to DEC-205 induces protection against the infection in mice.
Badillo-Godinez O; Gutierrez-Xicotencatl L; Plett-Torres T; Pedroza-Saavedra A; Gonzalez-Jaimes A; Chihu-Amparan L; Maldonado-Gama M; Espino-Solis G; Bonifaz LC; Esquivel-Guadarrama F
Vaccine; 2015 Aug; 33(35):4228-37. PubMed ID: 25850020
[TBL] [Abstract][Full Text] [Related]
19. Induction of virus-neutralizing antibodies by bacteria expressing the C3 poliovirus epitope in the periplasm. The route of immunization influences the isotypic distribution and the biologic activity of the antipoliovirus antibodies.
LeClerc C; Martineau P; Van der Werf S; Deriaud E; Duplay P; Hofnung M
J Immunol; 1990 Apr; 144(8):3174-82. PubMed ID: 2157762
[TBL] [Abstract][Full Text] [Related]
20. Functional mapping of protective epitopes within the rotavirus VP6 protein in mice belonging to different haplotypes.
Choi AH; McNeal MM; Basu M; Bean JA; VanCott JL; Clements JD; Ward RL
Vaccine; 2003 Jan; 21(7-8):761-7. PubMed ID: 12531356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
